785 related articles for article (PubMed ID: 8443388)
41. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
[TBL] [Abstract][Full Text] [Related]
42. Analysis of the involvement of the von Willebrand factor-glycoprotein Ib interaction in platelet adhesion to a collagen-coated surface under flow conditions.
Moroi M; Jung SM; Nomura S; Sekiguchi S; Ordinas A; Diaz-Ricart M
Blood; 1997 Dec; 90(11):4413-24. PubMed ID: 9373252
[TBL] [Abstract][Full Text] [Related]
43. Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditions.
Goto S; Tamura N; Handa S; Arai M; Kodama K; Takayama H
Circulation; 2002 Jul; 106(2):266-72. PubMed ID: 12105169
[TBL] [Abstract][Full Text] [Related]
44. Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation.
De Marco L; Girolami A; Russell S; Ruggeri ZM
J Clin Invest; 1985 Apr; 75(4):1198-203. PubMed ID: 3157702
[TBL] [Abstract][Full Text] [Related]
45. Platelet adhesion to multimeric and dimeric von Willebrand factor and to collagen type III preincubated with von Willebrand factor.
Wu YP; van Breugel HH; Lankhof H; Wise RJ; Handin RI; de Groot PG; Sixma JJ
Arterioscler Thromb Vasc Biol; 1996 May; 16(5):611-20. PubMed ID: 8963717
[TBL] [Abstract][Full Text] [Related]
46. A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction, and the presence of all von Willebrand factor multimers in plasma.
Casonato A; De Marco L; Mazzucato M; De Angelis V; De Roia D; Fabris F; Ruggeri ZM; Girolami A
Blood; 1989 Nov; 74(6):2028-33. PubMed ID: 2804346
[TBL] [Abstract][Full Text] [Related]
47. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
de Romeuf C; Hilbert L; Mazurier C
Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
[TBL] [Abstract][Full Text] [Related]
48. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
Azzam K; Cissé-Thiam M; Drouet L
Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802
[TBL] [Abstract][Full Text] [Related]
49. Shear-stress-induced von Willebrand factor binding to platelets causes the activation of tyrosine kinase(s).
Razdan K; Hellums JD; Kroll MH
Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):681-6. PubMed ID: 7524475
[TBL] [Abstract][Full Text] [Related]
50. Direct demonstration of radiolabeled von Willebrand factor binding to platelet glycoprotein Ib and IIb-IIIa in the presence of shear stress.
McCrary JK; Nolasco LH; Hellums JD; Kroll MH; Turner NA; Moake JL
Ann Biomed Eng; 1995; 23(6):787-93. PubMed ID: 8572428
[TBL] [Abstract][Full Text] [Related]
51. On the role of von Willebrand factor in promoting platelet adhesion to fibrin in flowing blood.
Endenburg SC; Hantgan RR; Lindeboom-Blokzijl L; Lankhof H; Jerome WG; Lewis JC; Sixma JJ; de Groot PG
Blood; 1995 Dec; 86(11):4158-65. PubMed ID: 7492773
[TBL] [Abstract][Full Text] [Related]
52. Mutant botrocetin-2 inhibits von Willebrand factor-induced platelet agglutination.
Matsui T; Hori A; Hamako J; Matsushita F; Ozeki Y; Sakurai Y; Hayakawa M; Matsumoto M; Fujimura Y
J Thromb Haemost; 2017 Mar; 15(3):538-548. PubMed ID: 28071872
[TBL] [Abstract][Full Text] [Related]
53. Simple collagen-like peptides support platelet adhesion under static but not under flow conditions: interaction via alpha2 beta1 and von Willebrand factor with specific sequences in native collagen is a requirement to resist shear forces.
Verkleij MW; Morton LF; Knight CG; de Groot PG; Barnes MJ; Sixma JJ
Blood; 1998 May; 91(10):3808-16. PubMed ID: 9573018
[TBL] [Abstract][Full Text] [Related]
54. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity.
Barstad RM; Stephens RW; Hamers MJ; Sakariassen KS
Thromb Haemost; 2000 Feb; 83(2):334-7. PubMed ID: 10739395
[TBL] [Abstract][Full Text] [Related]
55. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors.
De Marco L; Mazzuccato M; Grazia Del Ben M; Budde U; Federici AB; Girolami A; Ruggeri ZM
J Clin Invest; 1987 Aug; 80(2):475-82. PubMed ID: 3038958
[TBL] [Abstract][Full Text] [Related]
56. High shear dependent von Willebrand factor self-assembly fostered by platelet interaction and controlled by ADAMTS13.
Kragh T; Napoleone M; Fallah MA; Gritsch H; Schneider MF; Reininger AJ
Thromb Res; 2014 Jun; 133(6):1079-87. PubMed ID: 24681085
[TBL] [Abstract][Full Text] [Related]
57. Functional significance of adenosine 5'-diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate.
Goto S; Tamura N; Eto K; Ikeda Y; Handa S
Circulation; 2002 May; 105(21):2531-6. PubMed ID: 12034661
[TBL] [Abstract][Full Text] [Related]
58. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
[TBL] [Abstract][Full Text] [Related]
59. von Willebrand factor and platelet interactions with the vessel wall.
Fressinaud E; Meyer D
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):333-40. PubMed ID: 1893064
[TBL] [Abstract][Full Text] [Related]
60. Platelet size distribution measurements as indicators of shear stress-induced platelet aggregation.
Slack SM; Jennings LK; Turitto VT
Ann Biomed Eng; 1994; 22(6):653-9. PubMed ID: 7532923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
